
DRIO • NASDAQ
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold DRIO in your mock portfolio yet.
DarioHealth remains unprofitable, as reflected in its negative EPS and PE ratio. The lack of earnings suggests that, despite any potential growth in users or engagement, the business model has not yet translated into sustainable profitability. Without clear evidence of improving margins or a path to break-even, the financial picture is currently weak.
The stock’s modest 1.2% gain over the last month, combined with an RSI of 55, suggests a balanced market with neither strong buying nor selling pressure. Trading slightly below its 200-day moving average indicates the longer-term trend is still mildly negative or flat, but not in a steep downtrend. Overall, the technical picture is mixed and does not strongly signal either a breakout or a breakdown.
Alternative data shows strong product-level traction, especially through a sharp increase in app downloads, which can be a leading indicator of future revenue growth. Web traffic is modest but the surge in mobile app adoption suggests rising user engagement and potential scaling of the platform. Hiring has slowed slightly and social media followers are mostly flat to slightly down, but LinkedIn growth and app momentum tilt the alternative data picture positive.
Overall, DarioHealth presents a mixed picture: strong alternative data signals around app adoption contrast with weak profitability and only mildly constructive technicals. The stock appears to be in a wait-and-see phase where future performance will hinge on converting user growth into sustainable revenue and earnings. Until there is clearer evidence of improving financials, the risk-reward profile remains balanced rather than clearly attractive or unattractive.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: